4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF

The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression o...

Full description

Saved in:
Bibliographic Details
Main Authors CLEATOR, EDWARD, DIEGUEZ VAZQUEZ, ALEJANDRO, SONG, ZHIGUO JAKE, KONG, JONGROCK, KEEN, STEPHEN PHILIP, MOORE, JEFFREY C, GIBSON, ANDREW WILLIAM, LIEBERMAN, DAVID R, WILLIAMS, MICHAEL J, MCLAUGHLIN, MARK, PENG, FENG, GIRIJAVALLABHAN, VINAY M, MILCZEK, ERIKA M, BELYK, KEVIN M
Format Patent
LanguageEnglish
French
Published 18.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC. The present invention also provides processes for the preparation of 4'-substituted nucleoside derivatives of Formula (I) and derivatives thereof. La présente invention concerne des dérivés nucléosidiques substitués en position 4' de formule I et leur utilisation dans l'inhibition de la transcriptase inverse du VIH, la prophylaxie d'une infection par le VIH, le traitement d'une infection par le VIH, et la prophylaxie, le traitement et le retardement de l'apparition ou de la progression du SIDA et/ou du complexe associé au SIDA. La présente invention concerne également des procédés pour la préparation de dérivés nucléosidiques substitués en position 4' de formule I et des dérivés de ceux-ci.
AbstractList The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC. The present invention also provides processes for the preparation of 4'-substituted nucleoside derivatives of Formula (I) and derivatives thereof. La présente invention concerne des dérivés nucléosidiques substitués en position 4' de formule I et leur utilisation dans l'inhibition de la transcriptase inverse du VIH, la prophylaxie d'une infection par le VIH, le traitement d'une infection par le VIH, et la prophylaxie, le traitement et le retardement de l'apparition ou de la progression du SIDA et/ou du complexe associé au SIDA. La présente invention concerne également des procédés pour la préparation de dérivés nucléosidiques substitués en position 4' de formule I et des dérivés de ceux-ci.
Author GIBSON, ANDREW WILLIAM
MCLAUGHLIN, MARK
KONG, JONGROCK
LIEBERMAN, DAVID R
MILCZEK, ERIKA M
BELYK, KEVIN M
DIEGUEZ VAZQUEZ, ALEJANDRO
PENG, FENG
GIRIJAVALLABHAN, VINAY M
CLEATOR, EDWARD
KEEN, STEPHEN PHILIP
WILLIAMS, MICHAEL J
MOORE, JEFFREY C
SONG, ZHIGUO JAKE
Author_xml – fullname: CLEATOR, EDWARD
– fullname: DIEGUEZ VAZQUEZ, ALEJANDRO
– fullname: SONG, ZHIGUO JAKE
– fullname: KONG, JONGROCK
– fullname: KEEN, STEPHEN PHILIP
– fullname: MOORE, JEFFREY C
– fullname: GIBSON, ANDREW WILLIAM
– fullname: LIEBERMAN, DAVID R
– fullname: WILLIAMS, MICHAEL J
– fullname: MCLAUGHLIN, MARK
– fullname: PENG, FENG
– fullname: GIRIJAVALLABHAN, VINAY M
– fullname: MILCZEK, ERIKA M
– fullname: BELYK, KEVIN M
BookMark eNqFyj0LwjAQgOEMOvj1G8zm1EVLsWOaXOmBJOXu4lqKxEnSQv3_6ODu9PLAu1WrPOW0UVyeCo4NC0oUcNpHe4PA6EAT3IEYtJDxbAl7MV-h77BBCcTaeKd7gt6QEQyetXRAENq9Wj_H15IOv-7UsQWxXZHmaUjLPD5STu_BmnNdX6uyspf_xwexYTFb
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS NUCLEOSIDIQUES DE LA TRANSCRIPTASE INVERSE SUBSTITUES EN POSITION 4' ET PREPARATIONS ASSOCIEES
ExternalDocumentID CA2998646C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2998646C3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:25:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2998646C3
Notes Application Number: CA20162998646
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210518&DB=EPODOC&CC=CA&NR=2998646C
ParticipantIDs epo_espacenet_CA2998646C
PublicationCentury 2000
PublicationDate 20210518
PublicationDateYYYYMMDD 2021-05-18
PublicationDate_xml – month: 05
  year: 2021
  text: 20210518
  day: 18
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies MERCK SHARP & DOHME LIMITED
MERCK SHARP & DOHME CORP
RelatedCompanies_xml – name: MERCK SHARP & DOHME LIMITED
– name: MERCK SHARP & DOHME CORP
Score 3.3301353
Snippet The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Title 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210518&DB=EPODOC&locale=&CC=CA&NR=2998646C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z06g3nZr53YOZJyJj0I0DMVBKwDggtCy7GT5q9MIWh_Hft-CmXnbrR_LS_pLfe319fa8Ad0I0wcwCK8VQKxRdjDTFHJuaIrIxFlpuFKXRJDhPQ-yn-tPcmHfgbZML09YJ_WqLI0pGFZLvdauvl3-XWG77tnL1kL_LocWjxy13sPaOpf9iSDq7jkXjyI3IgBCL2IMwsaTWnWAdkx3YlYfoccMFOnOanJTlf4PiHcFeLGVV9TF0RNWDA7L5d60H-9N1uFs218xbnQDT7xWWOowHPJXKBoUpeaYRC1yKEjqjCaOIJ3bISBLE3Ja9IPQDJ-BRwpAdukgiHds_F1IMcZ8mNPJO4dajnPiKXN3LLxAvxN5sY3QG3WpRiT6g0jSzTMVZhsVQL001V4tXo9QnJS5NYajqOfS3SbnYPnUJhw2cTZx8OLmCbv3xKa6l-a3zmxa5b2SFhCU
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3rZr6LAdTT0RKYVsOxMCyBLQFwi6Nt4bHGr3QxmL8-y7Yqpfe9pFMdr_km9nZ2ZkFuOO8DmbmSM6Hai5rfKTKxthQZZ6OEVczPS_0OsF5FiAv0Z5e9JcWvG1zYZo6oV9NcUTBqFzwvWr09ervEstp3lauH7J3MbR8dJnpDDbesfBfdEFnxzZJFDohHmBsYmsQxKbQuhOkIbwH--KAPa65QOZ2nZOy-m9Q3GM4iISssjqBFi-70MHbf9e6cDjbhLtFc8O89SlQ7V6miU2ZzxKhbKQgwVMSUt8hUkzmJKZEYrEVUBz7EbNEzw883_ZZGFPJChxJIB1ZPxdSVGIeiUnonkHfJQx7sljd4heIBba22xidQ7tclrwHUmEYaaqgNEV8qBWGkin5q15okwIVBtcV5QJ6u6Rc7p7qQ8djs-li6gfPV3BUQ1vHzIeTa2hXH5_8RpjiKrttUPwGww-HGA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4%27-SUBSTITUTED+NUCLEOSIDE+REVERSE+TRANSCRIPTASE+INHIBITORS+AND+PREPARATIONS+THEREOF&rft.inventor=CLEATOR%2C+EDWARD&rft.inventor=DIEGUEZ+VAZQUEZ%2C+ALEJANDRO&rft.inventor=SONG%2C+ZHIGUO+JAKE&rft.inventor=KONG%2C+JONGROCK&rft.inventor=KEEN%2C+STEPHEN+PHILIP&rft.inventor=MOORE%2C+JEFFREY+C&rft.inventor=GIBSON%2C+ANDREW+WILLIAM&rft.inventor=LIEBERMAN%2C+DAVID+R&rft.inventor=WILLIAMS%2C+MICHAEL+J&rft.inventor=MCLAUGHLIN%2C+MARK&rft.inventor=PENG%2C+FENG&rft.inventor=GIRIJAVALLABHAN%2C+VINAY+M&rft.inventor=MILCZEK%2C+ERIKA+M&rft.inventor=BELYK%2C+KEVIN+M&rft.date=2021-05-18&rft.externalDBID=C&rft.externalDocID=CA2998646C